Publication Information

{'id': 'https://openalex.org/W2169398950', 'doi': 'https://doi.org/10.1176/appi.ps.201100331', 'title': 'Medicare Part D Benzodiazepine Exclusion and Use of Psychotropic Medication by Patients With New Anxiety Disorders', 'display_name': 'Medicare Part D Benzodiazepine Exclusion and Use of Psychotropic Medication by Patients With New Anxiety Disorders', 'publication_year': 2012, 'publication_date': '2012-05-01', 'ids': {'openalex': 'https://openalex.org/W2169398950', 'doi': 'https://doi.org/10.1176/appi.ps.201100331', 'mag': '2169398950', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22549332', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4402160'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1176/appi.ps.201100331', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S171176648', 'display_name': 'Psychiatric Services', 'issn_l': '1075-2730', 'issn': ['1075-2730', '1557-9700'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316602', 'host_organization_name': 'American Psychiatric Association', 'host_organization_lineage': ['https://openalex.org/P4310316602'], 'host_organization_lineage_names': ['American Psychiatric Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://europepmc.org/articles/pmc4402160?pdf=render', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5032533520', 'display_name': 'Michael Ong', 'orcid': 'https://orcid.org/0000-0001-8530-7754'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Michael K. Ong', 'raw_affiliation_strings': ['Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.'], 'affiliations': [{'raw_affiliation_string': 'Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102894993', 'display_name': 'Lily Zhang', 'orcid': 'https://orcid.org/0000-0002-6251-6913'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lily Zhang', 'raw_affiliation_strings': ['Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.'], 'affiliations': [{'raw_affiliation_string': 'Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110507683', 'display_name': 'Haiyong Xu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Haiyong Xu', 'raw_affiliation_strings': ['Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.'], 'affiliations': [{'raw_affiliation_string': 'Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036222697', 'display_name': 'Francisca Azocar', 'orcid': 'https://orcid.org/0000-0001-8808-1770'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Francisca Azocar', 'raw_affiliation_strings': ['Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.'], 'affiliations': [{'raw_affiliation_string': 'Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5078628298', 'display_name': 'Susan L. Ettner', 'orcid': 'https://orcid.org/0000-0001-9445-8917'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Susan L. Ettner', 'raw_affiliation_strings': ['Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.'], 'affiliations': [{'raw_affiliation_string': 'Dr. Ong, Dr. Xu, and Dr. Ettner are affiliated with the Department of Medicine, University of California, Los Angeles (UCLA), 911 Broxton Ave., First Floor, Los Angeles, CA 90024 (e-mail: ). Ms. Zhang is with the UCLA Center for Health Services and Society and with the Semel Institute for Neuroscience and Human Behavior, UCLA. Dr. Azocar is with OptumHealth Behavioral Solutions, San Francisco. Dr. Ettner is also with the Department of Health Services, UCLA.', 'institution_ids': ['https://openalex.org/I161318765']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5032533520'], 'corresponding_institution_ids': ['https://openalex.org/I161318765'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.912, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 13, 'citation_normalized_percentile': {'value': 0.788837, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '63', 'issue': '7', 'first_page': '637', 'last_page': '642'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10496', 'display_name': 'Pharmaceutical Practices and Patient Outcomes', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2717', 'display_name': 'Geriatrics and Gerontology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10496', 'display_name': 'Pharmaceutical Practices and Patient Outcomes', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2717', 'display_name': 'Geriatrics and Gerontology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9741, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10537', 'display_name': 'Attention Deficit Hyperactivity Disorder', 'score': 0.9736, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/anti-anxiety-agents', 'display_name': 'Anti-Anxiety Agents', 'score': 0.55281603}], 'concepts': [{'id': 'https://openalex.org/C2778173252', 'wikidata': 'https://www.wikidata.org/wiki/Q83871', 'display_name': 'Benzodiazepine', 'level': 3, 'score': 0.80544126}, {'id': 'https://openalex.org/C558461103', 'wikidata': 'https://www.wikidata.org/wiki/Q154430', 'display_name': 'Anxiety', 'level': 2, 'score': 0.74530935}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.6364813}, {'id': 'https://openalex.org/C2909738485', 'wikidata': 'https://www.wikidata.org/wiki/Q62903', 'display_name': 'Anti-Anxiety Agents', 'level': 3, 'score': 0.55281603}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.48561636}, {'id': 'https://openalex.org/C2776317618', 'wikidata': 'https://www.wikidata.org/wiki/Q544006', 'display_name': 'Anxiety disorder', 'level': 3, 'score': 0.43141505}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.36576855}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.09347585}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001008', 'descriptor_name': 'Anxiety Disorders', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D001569', 'descriptor_name': 'Benzodiazepines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019458', 'descriptor_name': 'Insurance Coverage', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': True}, {'descriptor_ui': 'D008329', 'descriptor_name': 'Managed Care Programs', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': True}, {'descriptor_ui': 'D054524', 'descriptor_name': 'Medicare Part D', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': True}, {'descriptor_ui': 'D011619', 'descriptor_name': 'Psychotropic Drugs', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014151', 'descriptor_name': 'Anti-Anxiety Agents', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D001008', 'descriptor_name': 'Anxiety Disorders', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001569', 'descriptor_name': 'Benzodiazepines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001569', 'descriptor_name': 'Benzodiazepines', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019458', 'descriptor_name': 'Insurance Coverage', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008329', 'descriptor_name': 'Managed Care Programs', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054524', 'descriptor_name': 'Medicare Part D', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010818', 'descriptor_name': "Practice Patterns, Physicians'", 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': False}, {'descriptor_ui': 'D010818', 'descriptor_name': "Practice Patterns, Physicians'", 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011619', 'descriptor_name': 'Psychotropic Drugs', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D011619', 'descriptor_name': 'Psychotropic Drugs', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1176/appi.ps.201100331', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S171176648', 'display_name': 'Psychiatric Services', 'issn_l': '1075-2730', 'issn': ['1075-2730', '1557-9700'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316602', 'host_organization_name': 'American Psychiatric Association', 'host_organization_lineage': ['https://openalex.org/P4310316602'], 'host_organization_lineage_names': ['American Psychiatric Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4402160', 'pdf_url': 'https://europepmc.org/articles/pmc4402160?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402160', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22549332', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4402160', 'pdf_url': 'https://europepmc.org/articles/pmc4402160?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/10', 'display_name': 'Reduced inequalities', 'score': 0.8}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 17, 'referenced_works': ['https://openalex.org/W1972362505', 'https://openalex.org/W1980314306', 'https://openalex.org/W1990130089', 'https://openalex.org/W1997402220', 'https://openalex.org/W2001956495', 'https://openalex.org/W2024200013', 'https://openalex.org/W2084534763', 'https://openalex.org/W2100040723', 'https://openalex.org/W2105443205', 'https://openalex.org/W2112001002', 'https://openalex.org/W2144091409', 'https://openalex.org/W2157318351', 'https://openalex.org/W2158087005', 'https://openalex.org/W3149933978', 'https://openalex.org/W4234282766', 'https://openalex.org/W4239986561', 'https://openalex.org/W4240555248'], 'related_works': ['https://openalex.org/W4299915278', 'https://openalex.org/W4289989080', 'https://openalex.org/W4232294275', 'https://openalex.org/W2423486066', 'https://openalex.org/W2417565523', 'https://openalex.org/W2105517360', 'https://openalex.org/W2040883278', 'https://openalex.org/W2019864473', 'https://openalex.org/W1889369246', 'https://openalex.org/W139038528'], 'abstract_inverted_index': {'The': [0], 'Medicare': [1, 9, 32, 108], 'Modernization': [2], 'Act': [3], '(MMA)': [4], 'specifically': [5], 'excluded': [6], 'benzodiazepines': [7, 17, 147], 'from': [8, 57], 'Part': [10, 33], 'D': [11, 34], 'coverage': [12, 36], 'starting': [13], 'in': [14, 136, 168, 179, 199, 239], '2006;': [15], 'however,': [16], 'are': [18], 'an': [19], 'effective,': [20], 'low-cost': [21], 'treatment': [22], 'for': [23, 82, 146, 157, 162, 202, 242], 'anxiety.': [24], 'This': [25], 'study': [26, 51], 'evaluated': [27], 'the': [28, 31, 64, 114, 188, 214, 231], 'effect': [29], 'of': [30, 68, 99, 122, 128, 143, 154, 220, 226], 'benzodiazepine': [35, 116, 216], 'exclusion': [37, 117, 217, 232], 'among': [38, 106, 187], 'patients': [39, 52, 209], 'with': [40, 53, 89, 210, 235], 'new': [41, 54, 211], 'anxiety': [42, 55, 212], 'disorders.The': [43], 'authors': [44], 'used': [45, 93], 'a': [46, 58, 119, 129, 236], 'quasi-experimental': [47], 'cohort': [48], 'design': [49], 'to': [50, 94, 113, 184], 'diagnoses': [56], 'large': [59], 'national': [60], 'health': [61, 103], 'plan': [62], 'during': [63], 'first': [65], 'six': [66], 'months': [67], '2005,': [69], '2006,': [70], 'and': [71, 74, 85, 97, 102, 118, 148, 159, 170], '2007.': [72, 171], 'Logistic': [73], 'zero-truncated': [75], 'negative-binomial': [76], 'regression': [77], 'models': [78], 'using': [79], 'covered': [80, 144, 155, 240], 'claims': [81, 145, 156, 241], 'behavioral,': [83], 'medical,': [84], 'pharmaceutical': [86], 'care': [87, 104, 131, 204], 'linked': [88], 'eligibility': [90], 'files': [91], 'were': [92, 173, 193], 'estimate': [95], 'utilization': [96, 105, 180], 'costs': [98], 'psychotropic': [100, 150, 163, 185, 222, 243], 'medication': [101, 186], 'elderly': [107, 208], 'Advantage': [109, 133], 'enrollees': [110, 126, 134, 166], '(N=8,397)': [111], 'subject': [112], 'MMA': [115, 215], 'comparison': [120, 189], 'group': [121], 'near-elderly': [123], '(ages': [124], '60–64)': [125], '(N=1,657)': [127], 'managed': [130], 'plan.Medicare': [132], 'diagnosed': [135, 167], '2005': [137], 'had': [138], 'significantly': [139], '(p<.05)': [140], 'higher': [141], 'rates': [142, 153], 'all': [149], 'drugs,': [151], 'lower': [152, 160], 'nonbenzodiazepines,': [158], 'expenditures': [161, 182], 'drugs': [164, 223], 'than': [165], '2006': [169], 'There': [172, 191], 'no': [174, 194], 'significant': [175, 195], 'differences': [176], 'over': [177, 197], 'time': [178, 198], 'or': [181], 'related': [183], 'group.': [190], 'also': [192], 'changes': [196], 'outpatient': [200], 'visits': [201], 'behavioral': [203, 228], 'by': [205], 'either': [206], 'cohort.Among': [207], 'diagnoses,': [213], 'increased': [218, 227], 'use': [219], 'nonbenzodiazepine': [221], 'without': [224], 'substitution': [225], 'care.': [229], 'Overall,': [230], 'was': [233], 'associated': [234], 'modest': [237], 'increase': [238], 'medication.': [244]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2169398950', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-10T07:19:40.028603', 'created_date': '2016-06-24'}